The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD

Niek F. Casteleijn; A. Lianne Messchendorp; Edwin M. Spithoven; Hedwig M. d'Agnolo; Joost P. Drenth; Johan W. de Fijter; Dorien J. Peters; Mahdi Salih; Darius Soonawala; Folkert W. Visser; Jack F. Wetzels; Robert Zietse; Ron T. Gansevoort

doi:10.1093/ndt/gfw156.03

The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD

Niek F. Casteleijn, A. Lianne Messchendorp, Edwin M. Spithoven, Hedwig M. d'Agnolo, Joost P. Drenth, Johan W. de Fijter, Dorien J. Peters, Mahdi Salih, Darius Soonawala, Folkert W. Visser, Jack F. Wetzels, Robert Zietse, Ron T. Gansevoort

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Article number	SP012
Pages (from-to)	90-91
Number of pages	2
Journal	Nephrology, Dialysis, Transplantation
Volume	31
DOIs	https://doi.org/10.1093/ndt/gfw156.03
Publication status	Published - May-2016
Event	53rd ERA-EDTA Congress - Vienna, Austria Duration: 21-May-2016 → 24-May-2016

Access to Document

10.1093/ndt/gfw156.03

Handle.net

Persistent link

Cite this

Casteleijn, N. F., Messchendorp, A. L., Spithoven, E. M., d'Agnolo, H. M., Drenth, J. P., de Fijter, J. W., Peters, D. J., Salih, M., Soonawala, D., Visser, F. W., Wetzels, J. F., Zietse, R., & Gansevoort, R. T. (2016). The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD. Nephrology, Dialysis, Transplantation, 31, 90-91. Article SP012. https://doi.org/10.1093/ndt/gfw156.03

@article{cff6da3d2b944535bb97c9f2d20608d7,

title = "The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD",

author = "Casteleijn, {Niek F.} and Messchendorp, {A. Lianne} and Spithoven, {Edwin M.} and d'Agnolo, {Hedwig M.} and Drenth, {Joost P.} and {de Fijter}, {Johan W.} and Peters, {Dorien J.} and Mahdi Salih and Darius Soonawala and Visser, {Folkert W.} and Wetzels, {Jack F.} and Robert Zietse and Gansevoort, {Ron T.}",

year = "2016",

month = may,

doi = "10.1093/ndt/gfw156.03",

language = "English",

volume = "31",

pages = "90--91",

journal = "Nephrology, Dialysis, Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

note = "53rd ERA-EDTA Congress ; Conference date: 21-05-2016 Through 24-05-2016",

}

Casteleijn, NF , Messchendorp, AL, Spithoven, EM, d'Agnolo, HM, Drenth, JP, de Fijter, JW, Peters, DJ, Salih, M, Soonawala, D, Visser, FW, Wetzels, JF, Zietse, R & Gansevoort, RT 2016, 'The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD', Nephrology, Dialysis, Transplantation, vol. 31, SP012, pp. 90-91. https://doi.org/10.1093/ndt/gfw156.03

The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD. / Casteleijn, Niek F.; Messchendorp, A. Lianne; Spithoven, Edwin M. et al.
In: Nephrology, Dialysis, Transplantation, Vol. 31, SP012, 05.2016, p. 90-91.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - The DIPAK 1 Study

T2 - 53rd ERA-EDTA Congress

AU - Casteleijn, Niek F.

AU - Messchendorp, A. Lianne

AU - Spithoven, Edwin M.

AU - d'Agnolo, Hedwig M.

AU - Drenth, Joost P.

AU - de Fijter, Johan W.

AU - Peters, Dorien J.

AU - Salih, Mahdi

AU - Soonawala, Darius

AU - Visser, Folkert W.

AU - Wetzels, Jack F.

AU - Zietse, Robert

AU - Gansevoort, Ron T.

PY - 2016/5

Y1 - 2016/5

U2 - 10.1093/ndt/gfw156.03

DO - 10.1093/ndt/gfw156.03

M3 - Meeting Abstract

SN - 0931-0509

VL - 31

SP - 90

EP - 91

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

M1 - SP012

Y2 - 21 May 2016 through 24 May 2016

ER -